Ralf A. Hoffmann

No más puestos en curso

Finance

Health Technology

Perfil

Mr. Ralf A.
Hoffmann is Founder at AMP-Therapeutics GmbH and Head of Research at Deutsche Bank AG.
He joined Deutsche Bank in 1996.
He is Head of Global Macro and Risk Analysis.
From 2002 to 2010, he was Head of Global Risk Analysis at Deutsche Bank in London.
Mr. Hoffmann received Master degrees in economics from the University of Passau and in Southeast Asian studies from the University of London.

Antiguos cargos conocidos de Ralf A. Hoffmann.

Empresas	Cargo	Fin
AMP-Therapeutics GmbH AMP-Therapeutics GmbH Pharmaceuticals: MajorHealth Technology AMP-Therapeutics GmbH operates as a pharmaceutical company. It discovers and develops medicines and antibiotics for the treatment of drug resistant infections. The company was founded by Ralf A. Hoffmann in 2009 and is headquartered in Leipzig, Germany.	Fundador	-
Deutsche Bank AG (Broker) Deutsche Bank AG (Broker) Investment Banks/BrokersFinance Deutsche Bank AG (Broker) is the brokerage arm of Deutsche Bank AG (ETR: DBK) in Germany. Headquartered in Frankfurt, the firm was founded in 1870 and offers FX Prime Brokerage (FXPB) which enables clients to transact foreign exchange across an array of dealers utilizing Deutsche Bank credit lines to maintain anonymity, maximize operational and margin efficiency and reduce transactional costs.	Director de Investigación - Acciones	-

Ver el detalle de la experiencia de Ralf A. Hoffmann.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas